| Title |
Incidence of Malignancy and the Risk of Lymphoma in Japanese Patients with Rheumatoid Arthritis Compared to the General Population
|
|---|---|
| Published in |
Journal of Rheumatology, January 2015
|
| DOI | 10.3899/jrheum.140533 |
| Pubmed ID | |
| Authors |
Atsushi Hashimoto, Noriyuki Chiba, Hirotaka Tsuno, Akiko Komiya, Hiroshi Furukawa, Toshihiro Matsui, Jinju Nishino, Shigeto Tohma |
| Abstract |
Recent advances in the management of patients with rheumatoid arthritis (RA) increased the rates of disease remission and patient life expectancy, while malignancy has become a more common cause of death. Here, we report the incidence of malignancy in a nationwide survey of Japanese patients with RA compared to the general population, focusing on the risk of lymphoma, which often arises in patients with RA. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 70 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 10 | 14% |
| Researcher | 10 | 14% |
| Student > Ph. D. Student | 7 | 10% |
| Student > Postgraduate | 4 | 6% |
| Student > Bachelor | 4 | 6% |
| Other | 16 | 23% |
| Unknown | 19 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 53% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Engineering | 2 | 3% |
| Immunology and Microbiology | 1 | 1% |
| Agricultural and Biological Sciences | 1 | 1% |
| Other | 2 | 3% |
| Unknown | 25 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2022.
All research outputs
#7,960,693
of 25,374,917 outputs
Outputs from Journal of Rheumatology
#1,578
of 3,951 outputs
Outputs of similar age
#105,634
of 377,419 outputs
Outputs of similar age from Journal of Rheumatology
#23
of 73 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 377,419 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.